Refreshed just now
NIH awarded Eveliqure Biotechnologies GmbH contract 75N93020C00048 to fund cGMP manufacturing and lot release of the Shigetec vaccine for Phase 2 trials.
Why it’s here: NIH award funding cGMP manufacturing and Phase 2 clinical trials of a vaccine is biotechnology funded by a federal health agency, fitting the Biotechnology area's NIH/biosecurity programs.
Trace across the boardItem
AwardNational Institutes of HealthAug 31NIH awarded Eveliqure Biotechnologies GmbH contract 75N93020C00048 to fund cGMP manufacturing and lot release of the Shigetec vaccine for Phase 2 trials.$12.9M obligated75N93020C00048Eveliqure Biotechnologies GmbHBiotechLifecycle15 linked
Connected
15 links- MoneySystems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)Both involve National Institutes of Health, Department of Health and Human Services
- MoneyAccelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)Both involve National Institutes of Health, Department of Health and Human Services
- MoneyTranslational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Both involve National Institutes of Health, Department of Health and Human Services
- HillDraft Policy Update to the NIH Policy for Data and Safety MonitoringBoth involve National Institutes of Health, Department of Health and Human Services
- HillComments due: Draft Policy Update to the NIH Policy for Data and Safety MonitoringBoth involve National Institutes of Health, Department of Health and Human Services
- MoneyGenomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)Both involve National Institutes of Health, Department of Health and Human Services
- MoneyGenomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)Both involve National Institutes of Health, Department of Health and Human Services
- MoneyEMERGENT, LLC — National Institutes of Health award HHSN276201700089UBoth involve National Institutes of Health, Department of Health and Human Services
- MoneyImmune Tolerance Network (UM1 Clinical Trial Required)Both involve National Institutes of Health, Department of Health and Human Services
- MoneyBLACKSMITH MEDICINES, INC. — National Institutes of Health award 75N93022C00060Both involve National Institutes of Health, Department of Health and Human Services
- MoneyANIVIVE LIFESCIENCES INC — National Institutes of Health award 75N93024C00009Both involve National Institutes of Health, Department of Health and Human Services
- MoneyTHOMAS JEFFERSON UNIVERSITY — National Institutes of Health award HHSN272201700082CBoth involve National Institutes of Health, Department of Health and Human Services
- MoneyBAYLOR COLLEGE OF MEDICINE — National Institutes of Health award 75N92024F00001Both involve National Institutes of Health, Department of Health and Human Services
- MoneyNLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)Both involve National Institutes of Health, Department of Health and Human Services
- MoneySimulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)Both involve National Institutes of Health, Department of Health and Human Services
About
- National Institutes of Health
- Department of Health and Human Services